Company / Operating Cash Flow
ACCENDRA HEALTH INC/VA/ Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$101.8M
FY2025
5-year range
-$101.8M / $740.7M
FY2021-FY2025
Trend
-163.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$102M in FY2025 to $741M in FY2023.
Based on SEC 10-K filings.
-$102M in FY2025.
Declined from $741M to -$102M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow decreased 163.0% year-over-year.
- Peak operating cash flow was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$101.8M | -163.0% |
| FY2024 | $161.5M | -78.2% |
| FY2023 | $740.7M | +127.9% |
| FY2022 | $325.0M | +95.7% |
| FY2021 | $166.1M | -51.0% |
| FY2020 | $339.2M | +193.5% |
| FY2019 | $115.6M | +0.0% |
| FY2018 | $115.6M | +103.6% |
| FY2017 | $56.8M | -69.8% |
| FY2016 | $187.7M | -30.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026